Huiping Qiang

Phase 1b Study of Sintilimab Plus Anlotinib as First-line Therapy in Patients With Advanced NSCLC

Tianqing Chu, Runbo Zhong, Hua Zhong et al. · Journal of Thoracic Oncology · 2021 · 216 citations · Full text

Phase 1B, Advanced Nsclc, Sintilimab Plus Anlotinib +6

Effective low-dose Anlotinib induces long-term tumor vascular normalization and improves anti-PD-1 therapy

Peng Fan, Huiping Qiang, Zhenhua Liu et al. · Frontiers in Immunology · 2022 · 34 citations · Full text

Clinical characteristics and prognostic factors of surgically resected combined small cell lung cancer: a retrospective study

Yuqiong Lei, Hui Feng, Huiping Qiang et al. · Lung Cancer · 2020 · 25 citations

Retrospective Study, Prognostic Factors, Surgical Oncology +13

Pembrolizumab monotherapy or combination therapy for bone metastases in advanced non-small cell lung cancer: a real-world retrospective study

Huiping Qiang, Yuqiong Lei, Yinchen Shen et al. · Translational Lung Cancer Research · 2022 · 23 citations · Full text

Treatment efficacy of HER2-mutant lung adenocarcinoma by immune checkpoint inhibitors: a multicenter retrospective study

Xiangling Chu, Huiping Qiang, Mengqing Xie et al. · Cancer Immunology Immunotherapy · 2021 · 18 citations · Full text

Medicine, Immune Checkpoint Inhibitors, Immunology +9